Services Agreements in the Biotechnology Industry

670 Contracts & Agreements

Browse by Company

2seventy bio, Inc. (3 contracts)
89bio, Inc. (1)
ACADIA PHARMACEUTICALS INC (8)
Accustem Sciences Inc. (1)
Acorda Therapeutics (11)
Acurx Pharmaceuticals, LLC (1)
Adagio Therapeutics, Inc. (3)
Adaptimmune Therapeutics PLC (5)
ADMA BIOLOGICS, INC. (7)
ADURO BIOTECH, INC. (1)
Advaxis, Inc. (3)
Adverum Biotechnologies, Inc. (2)
Aeglea BioTherapeutics, Inc. (6)
Aerovate Therapeutics, Inc. (1)
AGENUS INC (3)
AKCEA THERAPEUTICS, INC. (3)
Akebia Therapeutics, Inc. (4)
Aldeyra Therapeutics, Inc. (1)
Allakos Inc. (1)
Allovir, Inc. (1)
ALNYLAM PHARMACEUTICALS, INC. (2)
AMARIN CORP PLC (1)
Amgen Inc. (1)
AmpliPhi Biosciences Corp (1)
Amplitude Healthcare Acquisition Corp (2)
ANAVEX LIFE SCIENCES CORP. (10)
Aprea Therapeutics, Inc. (2)
Aptevo Therapeutics Inc. (2)
Aravive, Inc. (2)
Arbutus Biopharma Corp (1)
Arcellx, Inc. (1)
ARDELYX, INC. (2)
ARENA PHARMACEUTICALS INC (4)
Arsanis, Inc. (7)
Artiva Biotherapeutics, Inc. (6)
ARYA Sciences Acquisition Corp II (2)
Atara Biotherapeutics, Inc. (10)
Athenex, Inc. (1)
ATOSSA GENETICS INC (1)
Aurinia Pharmaceuticals Inc. (1)
AVROBIO, Inc. (1)
Axovant Sciences Ltd. (6)
BELLICUM PHARMACEUTICALS, INC (1)
BICYCLE THERAPEUTICS Ltd (10)
Big Cypress Acquisition Corp. (1)
bioAffinity Technologies, Inc. (3)
BioAtla, Inc. (2)
BioCardia, Inc. (1)
BIOCEPT INC (3)
BioLife4D Corp (2)
BIOMARIN PHARMACEUTICAL INC (1)
BIOSPECIFICS TECHNOLOGIES CORP (2)
Bison Capital Acquisition Corp. (1)
Black Diamond Therapeutics, Inc. (2)
Blue Water Vaccines Inc. (5)
bluebird bio, Inc. (8)
Bolt Biotherapeutics, Inc. (1)
Bone Biologics Corp (1)
BriaCell Therapeutics Corp. (2)
BullFrog AI Holdings, Inc. (1)
Cabaletta Bio, Inc. (7)
CALADRIUS BIOSCIENCES, INC. (2)
CAPRICOR THERAPEUTICS, INC. (1)
CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (2)
Capstone Therapeutics Corp. (3)
CASTLE BIOSCIENCES INC (2)
CATALYST BIOSCIENCES, INC. (1)
Celldex Therapeutics, Inc. (5)
Cellectar Biosciences, Inc. (1)
Chanticleer Holdings, Inc. (1)
Chardan Healthcare Acquisition 2 Corp. (1)
Checkpoint Therapeutics, Inc. (2)
ChemoCentryx, Inc. (1)
CLEVELAND BIOLABS INC (1)
Clovis Oncology, Inc. (1)
Coherus BioSciences, Inc. (2)
COMPASS Pathways plc (2)
Consonance-HFW Acquisition Corp. (2)
CRISPR Therapeutics AG (1)
CTI BIOPHARMA CORP (1)
Cullinan Oncology, LLC (2)
CURIS INC (1)
CytoDyn Inc. (1)
CYTORI THERAPEUTICS, INC. (2)
CYTRX CORP (2)
Dermavant Sciences Ltd (2)
Diffusion Pharmaceuticals Inc. (3)
DYADIC INTERNATIONAL INC (4)
Dynamics Special Purpose Corp. (2)
DYNAVAX TECHNOLOGIES CORP (3)
Editas Medicine, Inc. (1)
Eidos Therapeutics, Inc. (1)
Eiger BioPharmaceuticals, Inc. (2)
Emerald Bioscience, Inc. (2)
Emergent BioSolutions Inc. (6)
Enochian Biosciences Inc (3)
Esperion Therapeutics, Inc. (1)
Evelo Biosciences, Inc. (2)
EVOLUTIONARY GENOMICS, INC. (1)
EXACT SCIENCES CORP (2)
EXICURE, INC. (1)
FENNEC PHARMACEUTICALS INC. (5)
Fibrocell Science, Inc. (1)
FIBROGEN INC (1)
FIVE PRIME THERAPEUTICS INC (1)
Flexion Therapeutics Inc (3)
GALECTIN THERAPEUTICS INC (3)
Galecto Inc. (1)
Galera Therapeutics, Inc. (1)
Gemphire Therapeutics Inc. (1)
Gene Biotherapeutics, Inc. (1)
GENEREX BIOTECHNOLOGY CORP (1)
Genprex, Inc. (1)
GERON CORP (3)
GLYCOMIMETICS INC (1)
Greater Cannabis Company, Inc. (3)
GT Biopharma, Inc. (8)
GTX INC (1)
HCW Biologics Inc. (2)
Health Sciences Acquisitions Corp (6)
HEAT BIOLOGICS, INC. (3)
HEMISPHERX BIOPHARMA INC (9)
HERON THERAPEUTICS, INC. (1)
HilleVax, Inc. (1)
HOOKIPA Pharma Inc. (1)
HUMANIGEN, INC (2)
Immix Biopharma, Inc. (3)
Immune Therapeutics, Inc. (1)
Immuneering Corp (1)
ImmunoCellular Therapeutics, Ltd. (6)
Immunome Inc. (1)
IMMUNOMEDICS INC (2)
Inhibrx, Inc. (4)
INSMED Inc (4)
Intec Parent Inc. (1)
Intellia Therapeutics, Inc. (2)
INTERCEPT PHARMACEUTICALS, INC. (6)
INTREXON CORP (3)
IO Biotech, Inc. (5)
IONIS PHARMACEUTICALS INC (8)
IOVANCE BIOTHERAPEUTICS, INC. (2)
IRONWOOD PHARMACEUTICALS INC (1)
Isoray, Inc. (8)
iTeos Therapeutics, Inc. (1)
Janux Therapeutics, Inc. (1)
KalVista Pharmaceuticals, Inc. (3)
KBL MERGER CORP. IV (1)
Kindred Biosciences, Inc. (2)
Kiniksa Pharmaceuticals, Ltd. (1)
Kiromic Biopharma, Inc. (1)
Kura Oncology, Inc. (2)
Lantern Pharma Inc. (1)
LifeSci Acquisition Corp. (1)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (3)
Locust Walk Acquisition Corp. (2)
MACROGENICS INC (1)
Magenta Therapeutics, Inc. (1)
MARIZYME INC (3)
Marker Therapeutics, Inc. (1)
MATEON THERAPEUTICS INC (2)
MEDICINOVA INC (4)
Medovex Corp. (1)
MiNK Therapeutics, Inc. (2)
MIRAGEN THERAPEUTICS, INC. (4)
Monte Rosa Therapeutics, Inc. (2)
MUSTANG BIO, INC. (3)
MYMETICS CORP (1)
Myovant Sciences Ltd. (9)
NantKwest, Inc. (6)
Natera, Inc. (4)
NAVIDEA BIOPHARMACEUTICALS, INC. (2)
NEUROBIOLOGICAL TECHNOLOGIES INC (3)
NEUROTROPE BIOSCIENCE, INC. (4)
Neurotrope, Inc. (5)
NEWLINK GENETICS CORP (1)
NORTHWEST BIOTHERAPEUTICS INC (6)
NOVAVAX INC (5)
NTN BUZZTIME INC (1)
OncBioMune Pharmaceuticals, Inc (1)
ONCOSEC MEDICAL Inc (1)
Opko Health, Inc. (1)
Orchard Therapeutics plc (2)
Organicell Regenerative Medicine, Inc. (1)
Orgenesis Inc. (5)
PALATIN TECHNOLOGIES INC (2)
Pfenex Inc. (2)
PharmaCyte Biotech, Inc. (1)
PhaseBio Pharmaceuticals Inc (2)
PIERIS PHARMACEUTICALS, INC. (2)
POLARITYTE, INC. (1)
PORTOLA PHARMACEUTICALS INC (2)
PROGENITY, INC. (2)
ProMIS Neurosciences Inc. (4)
Propanc Biopharma, Inc. (2)
Protagenic Therapeutics, Inc. (3)
PROTEON THERAPEUTICS INC (3)
PROTEOSTASIS THERAPEUTICS, INC. (1)
PTC THERAPEUTICS, INC. (2)
Q BioMed Inc. (1)
Qrons Inc. (7)
Radius Health, Inc. (15)
REXAHN PHARMACEUTICALS, INC. (1)
Rezolute, Inc. (2)
RHYTHM PHARMACEUTICALS, INC. (1)
RITTER PHARMACEUTICALS INC (1)
Savara Inc (4)
SEATTLE GENETICS INC (1)
Sensei Biotherapeutics, Inc. (2)
SERA PROGNOSTICS, INC. (1)
Sesen Bio, Inc. (1)
Shattuck Labs, Inc. (1)
Shuttle Pharmaceuticals Holdings, Inc. (3)
Silverback Therapeutics, Inc. (2)
Social Capital Suvretta Holdings Corp. III (10)
Sorrento Therapeutics, Inc. (1)
SPHERIX INC (2)
Spinning Eagle Acquisition Corp. (3)
Spring Bank Pharmaceuticals, Inc. (4)
SUNESIS PHARMACEUTICALS INC (9)
SYNLOGIC, INC. (10)
TG THERAPEUTICS, INC. (3)
Tonix Pharmaceuticals Holding Corp. (1)
TScan Therapeutics, Inc. (2)
U.S. Stem Cell, Inc. (2)
Ultragenyx Pharmaceutical Inc. (1)
Unicycive Therapeutics, Inc. (1)
uniQure N.V. (1)
United Therapeutics Corp (3)
Unity Biotechnology, Inc. (1)
VACCINEX, INC. (1)
Vaccitech plc (1)
Vaxart, Inc. (6)
VBI Vaccines Inc (8)
VERACYTE, INC. (2)
Vericel Corp (8)
Vigil Neuroscience, Inc. (2)
Viking Therapeutics, Inc. (3)
VistaGen Therapeutics, Inc. (2)
VITAL THERAPIES INC (15)
WINDTREE THERAPEUTICS INC (2)
Xencor Inc (1)
Xenetic Biosciences, Inc. (7)
Xilio Therapeutics, Inc. (2)
ZAFGEN, INC. (2)

Recent Contracts

Master Services Agreement, dated December 13, 2024, by and between the Company and Danforth Advisors, LLC (BullFrog AI Holdings, Inc., Filed With SEC on December 17, 2024)
Contingent Value Rights Agreement, dated as of December 13, 2024, by and among, Palvella Therapeutics, Inc. (formerly Pieris Pharmaceuticals, Inc.), Shareholder Representative... (PIERIS PHARMACEUTICALS, INC., Filed With SEC on December 16, 2024)
Business Services Agreement, dated as of July 1, 2023, by and between Kalaris Therapeutics, Inc. (formerly Theia Therapeutics, Inc.) and Samsara BioCapital, LLC (Allovir, Inc., Filed With SEC on December 9, 2024)
Biologics Master Services Agreement, effective July 10, 2024, by and between WuXi Biologics (Hong Kong) Limited) and Jade Biosciences, Inc (Aerovate Therapeutics, Inc., Filed With SEC on December 3, 2024)
Amendment to the Services Agreement, dated as of September 30, 2024, between the Registrant and CIC Innovation Communities, LLC (Cabaletta Bio, Inc., Filed With SEC on November 14, 2024)
Amendment to the Services Agreement, dated as of December 1, 2021, between the Registrant and CIC Innovation Communities, LLC (Cabaletta Bio, Inc., Filed With SEC on November 14, 2024)
Services Agreement, dated as of February 1, 2019, between the Registrant and CIC Innovation Communities, LLC (Cabaletta Bio, Inc., Filed With SEC on November 14, 2024)
Master Services Agreement for Viral Vector Services, dated as of September 15, 2024, between the Registrant and Henogen SRL, as part of Thermo Fisher Scientific (bluebird bio, Inc., Filed With SEC on November 14, 2024)
Master Services Agreement, effective as of August 15, 2024, between the Registrant and Danforth Global, Inc (Aldeyra Therapeutics, Inc., Filed With SEC on November 7, 2024)
Master Services Agreement between FUJIFILM DIOSYNTH BIOTECHNOLOGIES NORTH CAROLINA, INC, FUJIFILM DIOSYNTH BIOTECHNOLOGIES DENMARK APS and TG Therapeutics, Inc., effective October... (TG THERAPEUTICS, INC., Filed With SEC on November 7, 2024)
Amended and Restated Biologics Master Services Agreement, dated October 14, 2024, by and between the Company and WuXi Biologics (Hong Kong) Limited (Aeglea BioTherapeutics, Inc., Filed With SEC on October 15, 2024)
Form of Statement of Work Pursuant to Master Equipment and Services Agreement (Isoray, Inc., Filed With SEC on September 20, 2024)
Master Equipment and Services Agreement, dated as of September 18, 2024, by and between Perspective Therapeutics, Inc. and Comecer SpA (Isoray, Inc., Filed With SEC on September 20, 2024)
Commercial Manufacturing Services Agreement, dated November 3, 2017, by and between the Registrant and Thermo Fisher (successor in interest to Henogen SA) (bluebird bio, Inc., Filed With SEC on September 13, 2024)
Master Services Agreement, dated November 1, 2018, between Shuttle Pharmaceuticals, Inc. and Theradex Systems, Inc (Shuttle Pharmaceuticals Holdings, Inc., Filed With SEC on August 14, 2024)
Amendment No. 10 to Commercial Manufacturing Services Agreement between Atara Biotherapeutics, Inc. and Charles River Laboratories, Inc. dated May 31, 2024 (Atara Biotherapeutics, Inc., Filed With SEC on August 12, 2024)
Amendment No. 9 to Commercial Manufacturing Services Agreement between Atara Biotherapeutics, Inc. and Charles River Laboratories, Inc. dated April 30, 2024 (Atara Biotherapeutics, Inc., Filed With SEC on August 12, 2024)
Service Agreement, dated March 18, 2024, by and between BicycleTx Ltd. and Michael Charles Ferguson Hannay (BICYCLE THERAPEUTICS Ltd, Filed With SEC on August 6, 2024)
Master Services Agreement, dated June 25, 2024, by and between Kiniksa Pharmaceuticals (UK), Ltd. and Samsung Biologics Co., Ltd (Kiniksa Pharmaceuticals, Ltd., Filed With SEC on July 25, 2024)
Master Research Services Agreement, dated August 3, 2020, by and between the Registrant and GC Cell Corporation (Artiva Biotherapeutics, Inc., Filed With SEC on June 28, 2024)
Amendment No. 1 to Master Agreement for Manufacturing Services, dated June 16, 2020, by and between the Registrant and GC Cell Corporation (Artiva Biotherapeutics, Inc., Filed With SEC on June 28, 2024)
Master Agreement for Manufacturing Services, dated March 16, 2020, by and between the Registrant and GC Cell Corporation (f/k/a GC Lab Cell Corporation) (Artiva Biotherapeutics, Inc., Filed With SEC on June 28, 2024)
Master Research Services Agreement, dated October 1, 2022, by and between Proteomedix AG and Immunovia, AB (Blue Water Vaccines Inc., Filed With SEC on June 5, 2024)
China Clinical Trial Services Agreement, dated April 8, 2022, by and between BioAtla, Inc. and Himalaya Therapeutics Limited Company, as amended (BioAtla, Inc., Filed With SEC on May 14, 2024)
Statement of Work dated May 3, 2024 pursuant to Master Contract Services Agreement between Synlogic, Inc. and Azzur Group (d/b/a Azzur of New England LLC), SOW P-Cleanroom... (SYNLOGIC, INC., Filed With SEC on May 14, 2024)
Amendment No. 1 to Services Agreement, by and between Sensei Biotherapeutics, Inc. and Monomy Advisors, LLC, dated May 7, 2024 (Sensei Biotherapeutics, Inc., Filed With SEC on May 9, 2024)
Amendment No. 8 to Commercial Manufacturing Services Agreement between Atara Biotherapeutics, Inc. and Charles River Laboratories, Inc. dated March 31, 2024 (Atara Biotherapeutics, Inc., Filed With SEC on May 9, 2024)
Master Services Agreement (the Agreement), dated February 13, 2024, by and between Fujifilm Diosynth Biotechnologies UK Limited, Fujifilm Diosynth Biotechnologies Texas, LLC, and... (Savara Inc, Filed With SEC on May 9, 2024)
Advisory Services Agreement by and between the Registrant and Onaiza Cadoret-Manier dated March 15, 2024 (IONIS PHARMACEUTICALS INC, Filed With SEC on May 7, 2024)
Amended and Restated Transitional Services Agreement between 2seventy bio, Inc. and Nick Leschly, dated as of March 29, 2024 (2seventy bio, Inc., Filed With SEC on April 1, 2024)
Amended and Restated Transitional Services Agreement between 2seventy bio, Inc. and Nick Leschly, dated as of March 29, 2024 (incorporated by reference to the Current Report on... (2seventy bio, Inc., Filed With SEC on April 1, 2024)
Amendment No. 7 to Commercial Manufacturing Services Agreement between Atara Biotherapeutics, Inc. and Charles River Laboratories, Inc. dated January 31, 2024 (Atara Biotherapeutics, Inc., Filed With SEC on March 28, 2024)
Amendment No. 6 to Commercial Manufacturing Services Agreement between Atara Biotherapeutics, Inc. and Charles River Laboratories, Inc. dated December 30, 2023 (Atara Biotherapeutics, Inc., Filed With SEC on March 28, 2024)
Project Agreement dated January 2, 2024 with Patheon Manufacturing Services LLC, part of Thermo Fisher Scientific (GLYCOMIMETICS INC, Filed With SEC on March 27, 2024)
Amendment No. 2 to Services Agreement with Michael Breen, dated as of February 20, 2023 (GT Biopharma, Inc., Filed With SEC on March 26, 2024)
Amendment No. 3 to Master Services Agreement, dated August 3, 2023, by and between X4 Pharmaceuticals Inc., and Catalent (Arsanis, Inc., Filed With SEC on March 21, 2024)
Addendum to Statement of Work dated December 8, 2023 pursuant to Master Contract Services Agreement between Synlogic, Inc. and Azzur Group (d/b/a Azzur of New England LLC), SOW... (SYNLOGIC, INC., Filed With SEC on March 19, 2024)
Master Manufacturing Services Agreement and Product Agreement, dated August 3, 2015, by and between the Registrant and Patheon Pharmaceuticals Inc (ACADIA PHARMACEUTICALS INC, Filed With SEC on February 28, 2024)
Placement Agent and Advisory Services Agreement, dated February 7, 2024, between Shuttle Pharmaceuticals Holdings, Inc. and Boustead Securities, LLC (Shuttle Pharmaceuticals Holdings, Inc., Filed With SEC on February 13, 2024)
Transitional Services Agreement between 2seventy bio, Inc. and Nick Leschly, dated as of January 29, 2024 (2seventy bio, Inc., Filed With SEC on January 30, 2024)